ducovest

3020-OL:HK:HK-X DBMSCIUSA (HKD)

COMMON STOCK | Other |

Last Closing

USD 1371

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

There is no Profile data available for 3020-OL.HK.

Currency: HKD

Country : Hong Kong

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-17 )

Largest Industry Peers for Other

Symbol Name Price(Change) Market Cap
1863:HK China Longevity Group Company ..

N/A

 USD 1.17B
8355:HK I-CONTROL

N/A

 USD 0.39B
8343:HK HongGuang Lighting Holdings Co..

N/A

 USD 0.31B
0648:HK CHINA RENJ

N/A

 USD 0.12B
0177-OL:HK JIANGSU EXPRESS

N/A

 N/A
0240-OL:HK BUILD KING HOLD

N/A

 N/A
0243-OL:HK QPL INT'L

N/A

 N/A
0182-OL:HK CHINA WINDPOWER

N/A

 N/A
0259-OL:HK YEEBO (INT'L H)

N/A

 N/A
0187-OL:HK JINGCHENG MAC

N/A

 N/A

ETFs Containing 3020-OL:HK

DXZ:CA Dynamic Active U.S. Mid-C.. 11.35 % 0.87 %

N/A

 CAD 0.04B
IHF iShares U.S. Healthcare P.. 10.79 % 0.43 %

N/A

 N/A
TETF 6.19 % 0.64 %

N/A

 N/A
FHI-B:CA CI Health Care Giants Cov.. 5.55 % 0.00 %

N/A

 CAD 0.05B
FHI:CA CI Health Care Giants Cov.. 5.16 % 0.75 %

N/A

 CAD 0.10B
IAI iShares U.S. Broker-Deale.. 4.11 % 0.42 %

N/A

 N/A
LONG:CA CI Global Longevity Econo.. 4.01 % 0.00 %

N/A

 CAD 3.64M
VSMV VictoryShares US Multi-Fa.. 3.29 % 0.35 %

N/A

 USD 0.11B
CBUF:XETRA iShares MSCI World Health.. 3.16 % 0.00 %

N/A

 N/A
PSL Invesco DWA Consumer Stap.. 3.06 % 0.60 %

N/A

 USD 0.09B
HDIV 2.83 % 0.00 %

N/A

 N/A
TDOC:CA TD Global Healthcare Lead.. 2.34 % 0.00 %

N/A

 CAD 0.08B
FHH:CA First Trust AlphaDEX US H.. 2.32 % 0.77 %

N/A

 CAD 0.01B
FHH-F:CA First Trust AlphaDEX U.S... 2.32 % 0.00 %

N/A

 CAD 0.01B
FDWM Fidelity Covington Trust .. 1.90 % 0.00 %

N/A

 USD 3.56M
FLXG:LSE 1.87 % 0.00 %

N/A

 N/A
FRGE:LSE 1.87 % 0.00 %

N/A

 N/A
RYH 1.72 % 0.40 %

N/A

 N/A
DSTL Distillate US Fundamental.. 1.71 % 0.00 %

N/A

 USD 1.79B
ZHU:CA BMO Equal Weight US Healt.. 1.48 % 0.00 %

N/A

 CAD 0.01B
HONR 1.20 % 0.65 %

N/A

 N/A
CVY Invesco Zacks Multi-Asset.. 1.11 % 0.65 %

N/A

 USD 0.10B
SMD 0.45 % 0.10 %

N/A

 N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

N/A

 USD 0.08B
JKH iShares Morningstar Mid-C.. 0.00 % 0.30 %

N/A

 N/A
KCE SPDR® S&P Capital Market.. 0.00 % 0.35 %

N/A

 N/A
BOUT Innovator ETFs Trust - In.. 0.00 % 0.80 %

N/A

 USD 0.01B
RYF 0.00 % 0.40 %

N/A

 N/A
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

N/A

 N/A
WBIF WBI BullBear Value 3000 E.. 0.00 % 1.05 %

N/A

 N/A
XHS SPDR® S&P Health Care Se.. 0.00 % 0.35 %

N/A

 USD 0.09B
XXM:CA 0.00 % 0.68 %

N/A

 N/A
FSWD:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

N/A

 N/A
IFSW:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

N/A

 N/A
IBCZ:F iShares IV Public Limited.. 0.00 % 0.00 %

N/A

 N/A
IS07:F iShares IV Public Limited.. 0.00 % 0.00 %

N/A

 N/A
IS07:XETRA iShares Edge MSCI World M.. 0.00 % 0.00 %

N/A

 N/A
IMCG iShares Morningstar Mid-C.. 0.00 % 0.00 %

N/A

 N/A

Market Performance

  Market Performance vs. Industry/Classification (Other) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.88% 51% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.88% 51% F 51% F
Trailing 12 Months  
Capital Gain 12.70% 72% C 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.70% 68% D+ 68% D+
Trailing 5 Years  
Capital Gain 121.31% 85% B 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 121.31% 85% B 87% B+
Average Annual (5 Year Horizon)  
Capital Gain 14.94% 76% C+ 75% C
Dividend Return 14.94% 70% C- 73% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 18.04% 79% B- 81% B-
Risk Adjusted Return 82.79% 95% A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike